Meanwhile, SPP1 was also a potential ICI inhibitor and could not only up-regulate PD-L1 on the surface of TAMs but also decrease the anti-tumor effect of CD8+T and the activation of CD4+T cells (52, 53, 68). This evidence concerns the gene CD8A and neoplasm.